QA: Sage Therapeutics Inc in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001597553_2019_Sage_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001597553, Sage Therapeutics Inc

  xvar xval
0 AssetsCurrent 944,695,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 5,643,000
3 remainder_Assets 2,367,000
4 LiabilitiesCurrent 86,030,000
5 LiabilitiesNoncurrent 3,704,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 201,404,000
9 ResearchAndDevelopmentExpense 282,107,000
10 remainder_Expenses 0
11 remainder_Revenues 90,273,000
12 remainder_NetIncome 20,356,000
13 remainder_ComprehensiveNetIncome -486,000
  yvar yval
0 Assets 952,705,000
1 Liabilities 89,734,000
2 Expenses 483,511,000
3 Revenues 90,273,000
4 StockholdersEquity 862,971,000
5 NetIncome -372,882,000
6 ComprehensiveNetIncome -373,125,000
7 BaseVar 818,532,500
8 EconomicCapitalRatiobeforeLimitedLiability 2.89
9 EconomicCapitalRatio 3.62

Edgar->Model Mapping

Feature Distribution